Tag Archive | "FDA Warning"
Healthy People Co. Dietary Supplements: Recall – Undeclared Drug Ingredient
Recalled products pose significant risk to patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Continue reading...Gris-PEG (griseofulvin ultramicrosize): Health Advisory – Risk of Product Mix-Up
Friday, February 3, 2012
Comments Off
During packaging and labeling, tablets from one product type may have carried over into packaging of another product.
Continue reading...Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall – Visible Glass Particle
Friday, February 3, 2012
Comments Off
Use of an inhaled product with glass particles has the potential to cause choking which could be life-threatening.
Continue reading...Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall – Possibility of Inexact Tablet Counts or Out of Sequence Tablets
Wednesday, February 1, 2012
Comments Off
Oral contraceptive daily regimen may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy.
Continue reading...Vitaflo USA Renastart: Recall – Possible Health Risk Due To Incorrectly Labeled Cans
Tuesday, January 31, 2012
Comments Off
Consequences of using the incorrectly labeled product may result in high potassium blood levels (hyperkalemia) or high sodium levels in the blood (hypernatremia).
Continue reading...Treanda (bendamustine HCL): Recall – Particulate Matter in Vial
Monday, January 30, 2012
Comments Off
Potential adverse events after intravenous administration of solutions containing particulates may include emboli and result in disruption of blood flow, causing tissue/organ damage.
Continue reading...Tysabri (natalizumab): Drug Safety Communication – New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML)
Friday, January 20, 2012
Comments Off
The risks and benefits of continuing treatment with Tysabri should be carefully considered in patients who are found to be anti-JCV antibody positive and have one or more of the other known risk factors for PML.
Continue reading...Perfect Image Solutions Topical Hair Regrowth Products: Recall – Unapproved Drugs, Risk of Health Hazards
Friday, January 20, 2012
Comments Off
Systemic absorption of topically administered Minoxidil could cause low blood pressure, heart palpitations and associated cardiac symptoms.
Continue reading...Vagifresh Ball, Vagifresh Gel, Female One: Recall – Undeclared Drug Ingredient, Bacterial Contamination
Friday, January 20, 2012
Comments Off
Possibility of an adverse reaction or unknown drug-drug interaction.
Continue reading...Adcetris (brentuximab vedotin): Drug Safety Communication – Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity
Friday, January 13, 2012
Comments Off
New Boxed Warning and Contraindication highlighting these risks added to product labeling.
Continue reading...
Monday, February 6, 2012
Comments Off